S. Eikawa

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
S Eikawa, S. Eikawa, Shingo Eikawa
Publication record
41 papers · 1,174 citations · H-index 13

PAPERS

Humoral IgG1 responses to tumor antigens underpin clinical outcomes in immune checkpoint blockade.
20260 citationsauthor #26
Abstract B026: αvβ5 Integrin serves as a tumor-specific marker for immunosuppressive regulatory T cells in pancreatic cancer
20240 citationsauthor #4
Tumor-resident regulatory T cells in pancreatic cancer express the αvβ5 integrin as a targetable activation marker
20237 citationsauthor #4
Antitumor immunity as the basis for durable disease-free treatment-free survival in patients with metastatic urothelial cancer
202311 citationsauthor #8
Abstract 3381: Identifying tumor antigen-specific CD4+ T cell dysfunctional states by single cell transcriptomics in immunotherapy-treated cancer patients
20200 citationsauthor #2
Dysfunction of CD8 + PD-1 + T cells in type 2 diabetes caused by the impairment of metabolism-immune axis
202046 citationsauthor #2
Berberine improved experimental chronic colitis by regulating interferon-γ- and IL-17A-producing lamina propria CD4+ T cells through AMPK activation
201966 citationsauthor #16
Abstract 4558: Mapping tolerized T cell states to exhaustion phenotypes in NSCLC
20190 citationsauthor #2
Metformin induces CD11b+-cell-mediated growth inhibition of an osteosarcoma: implications for metabolic reprogramming of myeloid cells and anti-tumor effects
2018101 citationsauthor #2
Attenuation of CD4+ CD25+ Regulatory T Cells in the Tumor Microenvironment by Metformin, a Type 2 Diabetes Drug
2017131 citationsauthor #2
Metformin-dependent metabolic reprogramming contributes to efficient anti-tumor immunity.
20170 citationsauthor #2
Abstract 5592: Metformin improves immune function of exhausted peripheral CD8+ T cells derived from cancer patients
20174 citationsauthor #2
[Metabolic Competition in Tumor Microenvironment].
201718 citationsauthor #1
Study about the Efficacy of Metformin to Immune Function in Cancer Patients.
20163 citationsauthor #3
Abstract 4865: Metformin improves multiple cytokine producing ability of exhausted peripheral CD8+ T cells of cancer patients
20160 citationsauthor #2
AntiTumor and Immunoregulatory Effects of Fermented Papaya Preparation (FPP: SAIDOPS501).
20168 citationsauthor #2
The induction of antigen-specific CTL by in situ Ad-REIC gene therapy
20166 citationsauthor #3
Detection and Tracking of NY-ESO-1-Specific CD8+ T Cells by High-Throughput T Cell Receptor β (TCRB) Gene Rearrangements Sequencing in a Peptide-Vaccinated Patient
20154 citationsauthor #2
The 2014 Incentive Award of the Okayama Medical Association in Cancer Research (2014 Hayashibara Prize and Yamada Prize)
20150 citationsauthor #1
The induction of antigen-specific CTL by in situ Ad-REIC gene therapy 2 3
20150 citationsauthor #3
Immune-mediated antitumor effect by type 2 diabetes drug, metformin
2015483 citationsauthor #1
Increase in Activated Treg in TIL in Lung Cancer and In Vitro Depletion of Treg by ADCC Using an Antihuman CCR4 mAb (KM2760)
201548 citationsauthor #5
Vaccination With NY-ESO-1 Overlapping Peptides Mixed With Picibanil OK-432 and Montanide ISA-51 in Patients With Cancers Expressing the NY-ESO-1 Antigen
201436 citationsauthor #5
[Regulation of T-cell immune exhaustion and cancer immunotherapy].
20142 citationsauthor #1
Monitoring multifunctionality of immune-exhausted CD8 T cells in cancer patients.
201412 citationsauthor #1
Expressing Tumors through Predominant - and IL-8 - Cells in Migrated T Cells to IL-6 Enrichment of Foxp3+ CD4 Regulatory T
20130 citationsauthor #4
Induction of CD8 T‐cell responses restricted to multiple HLA class I alleles in a cancer patient by immunization with a 20‐mer NY‐ESO‐1f (NY‐ESO‐1 91‐110) peptide
201330 citationsauthor #1
Abstract 4732: Depletion of Tregs from PBMCs by treatment with defucosylated anti-CCR4 mAb.
20138 citationsauthor #2
Abstract 495: Immune response to XAGE-1b (GAGED2a) in NSCLC patients and its clinical relevance.
20130 citationsauthor #3
Abstract 518: Immunogenicity of cancer/testis antigenXAGE-1din patients with non-small cell lung cancer (NSCLC)
20120 citationsauthor #3
HSP70 and HSP90 Differentially Regulate Translocation of Extracellular Antigen to the Cytosol for Cross-Presentation
201226 citationsauthor #6
Abstract 508: Correlation of antibody and T-cell responses against XAGE-1b in NSCLC patients
20120 citationsauthor #2
Spontaneous antibody, and CD4 and CD8 T‐cell responses against XAGE‐1b (GAGED2a) in non‐small cell lung cancer patients
201234 citationsauthor #2
Abstract 3653: Enrichment of Foxp3+ CD4 Tregs in migrated T-cells to IL-6- and IL-8-expressing tumors through predominant induction of CXCR1 by IL-6
20110 citationsauthor #1
Abstract 2689: XAGE-1b(GAGED2a) immunity in non-small cell lung cancer
20110 citationsauthor #2
This information is current as Induction of CXCR 1 by IL-6 Expressing Tumors through Predominant − and IL-8 − Cells in Migrated T Cells to IL-6 CD 4 Regulatory T + Enrichment of Foxp 3
20100 citationsauthor #1
Abstract 1915: Enrichment of Tregs in migrated T-cells to IL-6- and IL-8-expressing tumors through induction of CXCR1 by IL-6
20100 citationsauthor #1
Tumor immunity and immunosurveillance (PP-093)
20100 citationsauthor #75
Abstract 2394: Spontaneous immune responses against XAGE-1b in patients with non-small cell lung cancer (NSCLC)
20100 citationsauthor #2
Enrichment of Foxp3+ CD4 Regulatory T Cells in Migrated T Cells to IL-6– and IL-8–Expressing Tumors through Predominant Induction of CXCR1 by IL-6
201072 citationsauthor #1
Correlation of high and decreased NY-ESO-1 immunity to spontaneous regression and subsequent recurrence in a lung cancer patient.
200919 citationsauthor #2

TIMELINE

2009 19 citations

2010 72 citations

2011 0 citations

2012 60 citations

2013 38 citations

2014 50 citations

2015 535 citations

2016 17 citations

2017 153 citations

2018 101 citations

2019 66 citations

2020 46 citations

2023 18 citations

2024 0 citations

2026 0 citations

S. Eikawa

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT